Skip To Main Content

Logo Image

Who Classification Of Skin Tumours May 2026

: The term "variant" is now reserved strictly for genetic alterations in DNA sequences, rather than being used to describe morphological subtypes.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more WHO Classification of Skin Tumours

: The classification reaffirms the 9-pathway model for melanoma, which classifies lesions based on sun exposure (UV damage), anatomical site (e.g., acral, mucosal), and specific molecular drivers. : The term "variant" is now reserved strictly

Detailed information and purchasing options for the full volume are available through the IARC Publications or Amazon . AI responses may include mistakes

: This term is now used for "intermediate" lesions that exhibit borderline biological behavior but have specific molecular signatures (e.g., BAP1 inactivation or WNT pathway alterations).

: A new chapter focusing on the adverse prognostic implications of systemic cancers metastasizing to the skin.

: Each tumour entry includes clear "essential" diagnostic features and "desirable" criteria to improve diagnostic reliability worldwide. Major Clinical Updates by Category 1. Melanocytic Neoplasms

Logo Title

: The term "variant" is now reserved strictly for genetic alterations in DNA sequences, rather than being used to describe morphological subtypes.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

: The classification reaffirms the 9-pathway model for melanoma, which classifies lesions based on sun exposure (UV damage), anatomical site (e.g., acral, mucosal), and specific molecular drivers.

Detailed information and purchasing options for the full volume are available through the IARC Publications or Amazon .

: This term is now used for "intermediate" lesions that exhibit borderline biological behavior but have specific molecular signatures (e.g., BAP1 inactivation or WNT pathway alterations).

: A new chapter focusing on the adverse prognostic implications of systemic cancers metastasizing to the skin.

: Each tumour entry includes clear "essential" diagnostic features and "desirable" criteria to improve diagnostic reliability worldwide. Major Clinical Updates by Category 1. Melanocytic Neoplasms